Supplement Guide | Biomarkers 01 | Your Blood Work Is Trying to Tell You Something

This is Part 1 of SuppCo's four-part series on biomarkers and supplements. The series covers everything from how to interpret your results to the specific markers most relevant to supplement users… and what the evidence actually says about moving them.

Medicine has traditionally run on measurements. Your doctor takes your blood pressure → The lab checks your cholesterol → A number comes back → Someone decides what to do with it.

For most of medical history, that someone was a clinician, and the thing they decided was whether to prescribe a drug. The measurement existed to justify a treatment. The patient was mostly a passive participant in that transaction.

Supplements have never fit cleanly into that model. They're not drugs. They don't require a diagnosis (or a billing code). Most people take them based on a combination of general recommendations, marketing, and a best guess about what their body needs. For a long time, that was the only option available. You couldn't order your own labs. You couldn't track your own data. You were working blind.

That's changing. And the change is bigger than most people realize.

A biomarker is not just a number on a lab report. It's a window into a biological process that's happening right now, in your body, whether you're measuring it or not.

What a Biomarker Actually Is

The word gets used loosely, so it's worth being precise. Biomarkers are measurable signals in your body, like a hormone, protein, or vital sign, that can reflect shifts in your health even before symptoms show up. For example, elevated Apolipoprotein B levels can be linked to increased heart disease risk. Tracking biomarkers helps you spot changes early, so you can take action sooner.

Not all biomarkers are the same kind of useful, though. Some can be diagnostic: they may help confirm that a disease is present. Others can be predictive: they may signal elevated risk, often before symptoms arise. And some are pharmacodynamic: they tell you whether an intervention is working. That last category is the one that matters most when we're talking about supplements.

A pharmacodynamic marker moves in response to something you do. Triglycerides can change in response to omega-3 intake. RBC magnesium often responds to magnesium supplementation. Serum 25(OH)D often correlates to vitamin D3 intake. These aren't just abstract numbers. They're feedback. They can tell you whether what you're taking is actually doing anything.

Why This Matters More Now

For most of the supplement industry's history, the feedback loop didn't exist. You took a supplement, felt fine or didn't, and assumed it was working. There was no way to confirm. The evidence base existed at the population level, in clinical trials with set variables, but there was no mechanism for connecting that population-level data to your individual biology.

I know this problem from the inside. I spent years writing about supplement science while quietly aware that most people taking the supplements I was writing about had no idea whether any of it was working for them. The evidence was real. The mechanisms were solid. But without a way to measure your own response, it was all educated guesswork.

Direct-to-consumer lab testing closes that gap. When you can measure your own baseline, take an intervention, and remeasure six to twelve weeks later, the supplement question shifts from "does this work in general?" to "is this working for me?" That's a fundamentally different question, and it's one we're only recently equipped to ask.

The Supplement-Biomarker Connection Has Deep Roots

The idea that nutrients affect biological markers isn't new. It's one of the oldest threads in medicine. Sailors in the 1700s figured out that citrus prevented scurvy before anyone knew what vitamin C was or what it did at the cellular level. The measurement came later. The observation came first.

Modern nutrition science has spent decades formalizing that connection. We now know that specific nutrients affect specific pathways, which show up as measurable changes in specific markers. Ferritin clues us into iron status. Homocysteine levels clue us into B12 and folate status. Omega-3 intake shows up in the omega-3 index and may also affect fasting triglycerides. The science linking supplement intake to biomarker change is, in many cases, stronger than people realize.

What's been missing is the infrastructure to act on it at the individual level. That's what's now becoming available.

What Most Panels Miss

Standard lab work ordered by a primary care provider is designed to screen for the obvious problems: anemia, diabetes, thyroid dysfunction. 

What it often misses is the space between "normal" and "optimal," the range where you feel fine but your biology is quietly running below capacity.

Serum magnesium is a good example. It's the standard test, and it stays in the normal range until deficiency is severe. Red blood cell magnesium is a better reflection of actual cellular stores, a much more useful measure of functional status. Most standard panels don't run it. Expanded panels do.

The same logic applies across several markers. The question isn't just whether you're sick. It's whether your numbers reflect a body that's functioning as well as it could, and whether the gap between where you are and where you want to be is one that targeted supplementation can close.

The Right Way to Think About This

Biomarkers are not verdicts. A low vitamin D reading doesn't mean you're destined for poor immune function. An elevated fasting glucose doesn't mean diabetes is inevitable. What these markers do is give you a starting point, a specific, measurable place to focus.

I've lived this. My fasting glucose was higher than I wanted before adding berberine. Four months later it dropped 16 points. My vitamin D levels have come up meaningfully since I started supplementing D3+K2, which matters more than it sounds when you live in Boston and spend half the year under skies that seem personally committed to blocking sunlight. These weren't dramatic interventions. They were targeted ones, made possible by knowing what the numbers actually were.

That's the whole idea. The relationship between biomarkers and supplements works in both directions. The evidence base tells you which supplements have a track record of moving specific markers. Your lab results tell you which markers are worth targeting in the first place. Put those two things together and you have something much more useful than either one alone.

In Part 2, we get specific: eight curated markers, eight targeted interventions, and what the research actually shows about moving them. Some of the results surprised me. I think a few will surprise you too.